COVAXIN: Human trial of India's first COVID-19 vaccine begins at Rohtak, no adverse effects so far

Chandigarh, July 17: The human trial of Bharat Biotech's anti-COVID-19 vaccine Covaxin began at Rohtak's Post-Graduate Institute of Medical Sciences on Friday, Haryana Health Minister Anil Vij tweeted. "Human trial with Corona vaccine (COVAXIN) of Bharat Biotech started at

from India News, India Breaking News, Latest news headlines in India - Oneindia News https://ift.tt/3j7D3sq

• Tweet
• Share
• Share
• Share
• Share

About Admin MC3

This is dummy text. It is not meant to be read. Accordingly, it is difficult to figure out when to end it. But then, this is dummy text. It is not meant to be read. Period.

Related Post